These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 8740088)

  • 1. Pharmacological properties of quinoxaline derivatives as a new class of 5-HT3 receptor antagonists.
    Lasheras B; Berjón A; Montañés R; Roca J; Romero G; Ramírez MJ; Del Río J
    Arzneimittelforschung; 1996 Apr; 46(4):401-6. PubMed ID: 8740088
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pinacidil suppression on 5-HT3 receptor-mediated contraction of guinea pig ileum in vitro.
    Yuan YM; Xu DY; Hu GY
    Zhongguo Yao Li Xue Bao; 1998 Jan; 19(1):31-5. PubMed ID: 10375754
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 2,3-Dihydro-2-oxo-1H-benzimidazole-1-carboxamides with selective affinity for the 5-HT(4) receptor: synthesis and structure-affinity and structure-activity relationships of a new series of partial agonist and antagonist derivatives.
    Tapia I; Alonso-Cires L; López-Tudanca PL; Mosquera R; Labeaga L; Innerárity A; Orjales A
    J Med Chem; 1999 Jul; 42(15):2870-80. PubMed ID: 10425096
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tetraethylammonium and 4-aminopyridine enhancement of 5-HT3 receptor-mediated contraction of guinea pig ileum in vitro.
    Yuan YM; Yang HH; Hu GY
    Zhongguo Yao Li Xue Bao; 1998 Sep; 19(5):451-5. PubMed ID: 10375808
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anxiolytic-like effect of a serotonergic ligand with high affinity for 5-HT1A, 5-HT2A and 5-HT3 receptors.
    Delgado M; Caicoya AG; Greciano V; Benhamú B; López-Rodríguez ML; Fernández-Alfonso MS; Pozo MA; Manzanares J; Fuentes JA
    Eur J Pharmacol; 2005 Mar; 511(1):9-19. PubMed ID: 15777774
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Species difference in the 5-hydroxytryptamine3 receptor associated with the von Bezold-Jarisch reflex.
    Yamano M; Ito H; Kamato T; Miyata K
    Arch Int Pharmacodyn Ther; 1995; 330(2):177-89. PubMed ID: 8861711
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phenylimidazolidin-2-one derivatives as selective 5-HT3 receptor antagonists and refinement of the pharmacophore model for 5-HT3 receptor binding.
    Heidempergher F; Pillan A; Pinciroli V; Vaghi F; Arrigoni C; Bolis G; Caccia C; Dho L; McArthur R; Varasi M
    J Med Chem; 1997 Oct; 40(21):3369-80. PubMed ID: 9341912
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of various 5-HT3 receptor antagonists, granisetron, ondansetron, ramosetron and azasetron on serotonin (5-HT) release from the ferret isolated ileum.
    Endo T; Minami M; Kitamura N; Teramoto Y; Ogawa T; Nemoto M; Hamaue N; Hirafuji M; Yasuda E; Blower PR
    Res Commun Mol Pathol Pharmacol; 1999; 104(2):145-55. PubMed ID: 10634307
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The interaction of RS 25259-197, a potent and selective antagonist, with 5-HT3 receptors, in vitro.
    Wong EH; Clark R; Leung E; Loury D; Bonhaus DW; Jakeman L; Parnes H; Whiting RL; Eglen RM
    Br J Pharmacol; 1995 Feb; 114(4):851-9. PubMed ID: 7773546
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 5-Hydroxytryptamine3 receptor and regulation of gastric emptying in rats.
    Ito C; Isobe Y; Tsuchida K; Higuchi S
    Arch Int Pharmacodyn Ther; 1996; 331(2):203-18. PubMed ID: 8937630
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacological effects of the new gastroprokinetic agent mosapride citrate and its metabolites in experimental animals.
    Yoshida N; Omoya H; Kato S; Ito T
    Arzneimittelforschung; 1993 Oct; 43(10):1078-83. PubMed ID: 8267674
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pyrrolizidine esters and amides as 5-HT4 receptor agonists and antagonists.
    Becker DP; Flynn DL; Moormann AE; Nosal R; Villamil CI; Loeffler R; Gullikson GW; Moummi C; Yang DC
    J Med Chem; 2006 Feb; 49(3):1125-39. PubMed ID: 16451077
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemical modulation of 5-HT3 and 5-HT4 receptors affects the release of 5-hydroxytryptamine from the ferret and rat intestine.
    Minami M; Tamakai H; Ogawa T; Endo T; Hamaue N; Hirafuji M; Yoshioka M; Blower PR
    Res Commun Mol Pathol Pharmacol; 1995 Aug; 89(2):131-42. PubMed ID: 8556268
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacological characterization of a neuronal receptor for 5-hydroxytryptamine in guinea pig ileum with properties similar to the 5-hydroxytryptamine receptor.
    Craig DA; Clarke DE
    J Pharmacol Exp Ther; 1990 Mar; 252(3):1378-86. PubMed ID: 2319473
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of the receptor selectivity of the H3 receptor antagonists, iodophenpropit and thioperamide: an interaction with the 5-HT3 receptor revealed.
    Leurs R; Tulp MT; Menge WM; Adolfs MJ; Zuiderveld OP; Timmerman H
    Br J Pharmacol; 1995 Oct; 116(4):2315-21. PubMed ID: 8564266
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis of 2-piperazinylbenzothiazole and 2-piperazinylbenzoxazole derivatives with 5-HT3 antagonist and 5-HT4 agonist properties.
    Monge A; Peña MC; Palop JA; Calderó JM; Roca J; García E; Romero G; del Río J; Lasheras B
    J Med Chem; 1994 Apr; 37(9):1320-5. PubMed ID: 8176710
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SC-49518 enhances gastric emptying of solid and liquid meals and stimulates gastrointestinal motility in dogs by a 5-hydroxytryptamine4 receptor mechanism.
    Gullikson GW; Virina MA; Loeffler RF; Yang DC; Goldstin B; Wang SX; Moummi C; Flynn DL; Zabrowski DL
    J Pharmacol Exp Ther; 1993 Jan; 264(1):240-8. PubMed ID: 8380862
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Microwave assisted synthesis of 2-(4-substituted piperazin-1-yl)-1,8-naphthyridine-3-carbonitrile as a new class of serotonin 5-HT3 receptor antagonists.
    Mahesh R; Perumal RV; Pandi PV
    Bioorg Med Chem Lett; 2004 Oct; 14(20):5179-81. PubMed ID: 15380223
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel antagonists of 5-HT3 receptors. Synthesis and biological evaluation of piperazinylquinoxaline derivatives.
    Monge A; Palop JA; Del Castillo JC; Calderó JM; Roca J; Romero G; Del Río J; Lasheras B
    J Med Chem; 1993 Sep; 36(19):2745-50. PubMed ID: 8410988
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RS 23597-190: a potent and selective 5-HT4 receptor antagonist.
    Eglen RM; Bley K; Bonhaus DW; Clark RD; Hegde SS; Johnson LG; Leung E; Wong EH
    Br J Pharmacol; 1993 Sep; 110(1):119-26. PubMed ID: 8220871
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.